Karen Barth Menzies of Baum Hedlund provides a comprehensive update of SSRI developments
Etopia Media Medical News Network #99
Los Angeles, California
April 7, 2004
By Marc Strassman
This page and its contents are copyright © 2005 by Etopia Media News Networks. All rights in all media reserved.
Reporter
Etopia Media Medical News Network
Etopia Media News Networks

Karen Barth Menzies, Baum Hedlund, trial lawyer for Paxil addiction case patients
Karen Barth Menzies is a trial lawyer and a regular guest on Etopia Medical News Network. She was recently designated the lead trial lawyer in the multi-district case involving complaints against GlaxoSmithKline for alleged damage caused to people taking their Paxil anti-depressant.
On April 7, 2004, Ms. Menzies talked exclusively with Etopia Medical News Network about the Paxil addiction case, the FDA, the Congressional investigation into the FDA, pharmacologically "altered humans" on the Op-Ed page of the New York Times, the concept of a "pharmastate," and why Paxil is making GlaxoSmithKline rich while people selling LSD are more likely to be sent to jail than be feted by the Chamber of Commerce, even though the basic physiological mechanisms of action of Paxil and "acid" are the same.
You can hear that conversation by clicking here.
To visit the Baum Hedlund website, which contains an extensive collection of information about the Paxil addiction case, click here.
See what GlaxoSmithKline has to say about Paxil by clicking here.
Read "Is Psychiatry for Sale?" by Joanna Moncrieff by clicking here.
See the results of an Etopia Medical News Network poll about Paxil on the e-thePeople web site by clicking here.